Sluggish Year for IPOs, But Signs Abound of Post-Election Surge | Xconomy https://t.co/hmndySJ8zz — The Propell Group (@ThePropellGroup) November 23, 2016 #healthtech
Unfounded fears raised over Google’s DeepMind deal continue to undermine the NHS to use medical data https://t.co/RTx7UZUE8s via @FT — The Propell Group (@ThePropellGroup) November 23, 2016 #healthtech
Gut bacteria ‘may help drugs fight cancer’ – BBC News https://t.co/2e2PifDyFL — The Propell Group (@ThePropellGroup) November 22, 2016 #healthtech
How tech-enabled consumers are reordering the healthcare landscape @mckinsey https://t.co/KN3T5a5Wyj — The Propell Group (@ThePropellGroup) November 22, 2016 #healthtech
Innovation vs redecoration: corporates dilemma! pic.twitter.com/h81XOJAJgQ — The Propell Group (@ThePropellGroup) November 22, 2016 #healthtech
Doctor Behind Knock-Off “Cancer Moonshot” Meets with Trump https://t.co/IqaaFeKhIq — The Propell Group (@ThePropellGroup) November 22, 2016 #healthtech
Which startups are poised to change the world? https://t.co/aD5md7vWCV pic.twitter.com/2YewabWmwK — The Propell Group (@ThePropellGroup) November 22, 2016 #healthtech
Novartis acquires Selexys in deal worth up to $665m https://t.co/tgXezGdVVs via @FT — The Propell Group (@ThePropellGroup) November 21, 2016 #healthtech
VC 101: The Angel Investor’s Guide to Startup Investing https://t.co/MYw6HXGBZk — The Propell Group (@ThePropellGroup) November 21, 2016 #healthtech
ACA or Not, Accolade Sees Growing Demand For Healthcare Innovation | Xconomy https://t.co/KhWcYuHsMA — The Propell Group (@ThePropellGroup) November 21, 2016 #healthtech